Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Activating Tgr5 may help treat hair loss and bone loss.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

Frequent blood transfusions in beta thalassemia patients can lead to thyroid problems.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Retinoids might cause temporary hyperthyroidism in some patients.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Increasing TSPO in the brain may help improve memory problems.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Targeting the AhR pathway may help treat alopecia areata.

Mitochondrial stress can lead to atopic dermatitis.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.